Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a ...

While the Africentric Personal Development Shop may not be well known by the Greater Columbus community, CEO Jerry Saunders Sr. says it has the most important factor down — street credibility. Since ...

Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), an ultra-rare immunodeficiency ...

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Today, American Prison Data Systems (APDS), announces a major renaming effort to become Orijin. Like APDS, Orijin’s mission is to prepare every ...

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug ...

Pharming’s investigational treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) has been granted orphan drug designation from the European Commission. The designation awarded to ...

Please provide your email address to receive an email when new articles are posted on . There is no current treatment for children with APDS aged 4 to 11 years. Diagnostic delays have a mean of 7 ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...